Assignee
ASCENEURON SA
CH19 patents
Top patents by PatentIndex Score
US10336775B2Jul 2, 2019
Glycosidase inhibitors
ASCENEURON SA15 citations94
US10696668B2Jun 30, 2020
Acid addition salts of piperazine derivatives
ASCENEURON SA12 citations92
US11261183B2Mar 1, 2022
Sulfoximine glycosidase inhibitors
ASCENEURON SA11 citations85
US11213525B2Jan 4, 2022
Linear glycosidase inhibitors
ASCENEURON SA9 citations85
US11046712B2Jun 29, 2021
Glycosidase inhibitors
ASCENEURON SA11 citations85
US10995090B2May 4, 2021
Substituted dihydrobenzofuran glycosidase inhibitors
ASCENEURON SA11 citations85
US10556902B2Feb 11, 2020
Glycosidase inhibitors
ASCENEURON SA12 citations85
US10344021B2Jul 9, 2019
Process for the separation of enantiomers of piperazine derivatives
ASCENEURON SA15 citations84
US11591327B2Feb 28, 2023
Acid addition salts of piperazine derivatives
ASCENEURON SA6 citations83
US12187741B2Jan 7, 2025
Glycosidase inhibitors
ASCENEURON SA1 citations74
US11612599B2Mar 28, 2023
Glycosidase inhibitors
ASCENEURON SA6 citations74
US11795165B2Oct 24, 2023
Tetrahydro-benzoazepine glycosidase inhibitors
ASCENEURON SA5 citations73
US12016852B2Jun 25, 2024
Pyrrolidine glycosidase inhibitors
ASCENEURON SA4 citations72
US11731972B2Aug 22, 2023
Spiro compounds as glycosidase inhibitors
ASCENEURON SA5 citations72
US12195455B2Jan 14, 2025
Succinate and fumarate acid addition salts of piperazine derivatives
ASCENEURON SA1 citations63
US12157734B2Dec 3, 2024
Sulfoximine glycosidase inhibitors
ASCENEURON SA1 citations62
US12398130B2Aug 26, 2025
Acid addition salts of piperazine derivatives
ASCENEURON SA0 citations60
US11458140B2Oct 4, 2022
Annulated glycosidase inhibitors
ASCENEURON SA0 citations52
US9505769B2Nov 29, 2016
Tetraaza-cyclopenta[a]indenyl derivatives
ASCENEURON SA0 citations36